When hair testing fits
Hair follicle testing can fit selected employer-policy programs when scoped in advance.
- Policy-based screening
- Pre-employment workflows
- Role-specific testing decisions
Hair Testing
An employer-requested drug or alcohol test must match the employer’s actual order. Before the visit, establish whether the test is DOT-regulated or non-DOT, why it is required, which specimen is ordered and where the result must go.
Ask the employer to specify the hair test, laboratory, collection method and reporting process. A hair test is not an authorized substitute for the DOT drug test. Do not infer a precise detection window, current impairment or a substance-use diagnosis from the name alone. Confirm whether the clinic actually offers the requested collection and what happens if the required specimen cannot be collected.
An employer-requested drug or alcohol test must match the employer’s actual order. Before the visit, establish whether the test is DOT-regulated or non-DOT, why it is required, which specimen is ordered and where the result must go. A clinical drug test, a home test and a workplace collection do not automatically satisfy the same requirement. Bring the authorization rather than choosing a panel by its size or name.
A workplace testing program separates collection, laboratory analysis, medical review and the employer’s decision. DOT procedures require the correct custody-and-control process and an authorized laboratory. A medical review officer, or MRO, reviews applicable laboratory findings and legitimate medical explanations. Alcohol testing has its own equipment, technician and confirmation procedures. A negative result does not certify general fitness for duty, and a positive screening result alone does not diagnose a substance-use disorder.
The order may be for pre-employment, random, reasonable-suspicion, post-accident, return-to-duty or follow-up testing. These reasons have different program rules. DOT drug testing uses the substances specified in Part 40. A non-DOT 10-panel, instant screen, hair test or urine ETG alcohol test is not a substitute for the required DOT test. An employer’s non-DOT panel and state requirements must be confirmed separately, including whether cannabis testing is permitted for that role.
Check the authorized site, collection deadline, test reason and billing details with the employer or designated employer representative. Bring photo ID and the order. The collector confirms identity and follows the applicable collection process. Keep the collection receipt and the testing contact details. Respond promptly if the MRO contacts you for information. Ask the employer how it receives the final verified result and when you may start or resume work.
Follow the instructions on the actual order. Provide accurate contact information and have prescription records available for the MRO if requested. Keep medicines in their usual treatment plan unless your prescriber directs a change. Do not use detox products, substitute a specimen or attempt to alter the result. If you have difficulty providing the required specimen or need an accommodation, tell the collector immediately so the proper procedure can be followed.
Do not drive or perform safety-sensitive duties while impaired. After an accident, medical care comes first. The employer must determine the applicable testing trigger and route without delaying necessary treatment. Prescription use can require both result verification and a separate safety assessment. In DOT programs, state permission to use marijuana does not override federal testing rules. Speak with your prescriber about treatment safety; the collection visit is not a place to make an abrupt medication change.
A collection being finished does not mean the result is final. Laboratory work, specimen questions and MRO review may take additional time. DOT employees with a verified positive or other covered violation must follow the applicable substance-abuse-professional and return-to-duty process before resuming safety-sensitive duties. A new self-paid negative test does not erase that requirement. Ask the MRO immediately about any right to test the split specimen and the applicable deadline. Non-DOT disputes follow the actual program and law.
Before arranging an employer collection at Nao, share the written test order. Confirm the exact panel, specimen, DOT status, laboratory route, MRO arrangements, hours, reporting and cost before attending. For a group, mobile or after-hours collection, ask which sites, times and qualified staff are available under your employer’s agreement. DOT oral-fluid collection also requires the current approved laboratory and device pathway; the regulation’s availability does not establish that a particular clinic offers it. TLC drug testing follows TLC’s separate approved-site instructions.
Ask the employer to specify the hair test, laboratory, collection method and reporting process. A hair test is not an authorized substitute for the DOT drug test. Do not infer a precise detection window, current impairment or a substance-use diagnosis from the name alone. Confirm whether the clinic actually offers the requested collection and what happens if the required specimen cannot be collected.
Confirm whether the employer-service team can provide the requested services in each worker's state before arranging a nationwide program. Send the job groups, worker locations, governing rules, tests, headcount, deadline and billing/reporting needs to Nao's employer-service team. Request a written state-by-state site and professional roster, actual scope and escalation contacts. A nationwide website claim does not establish an operating clinic, qualified examiner, collection route or contract in each state.
An employer consultation defines the organization's program, sites, authorizations, billing and reports. It is different from an employee's clinical appointment. Employers should send the service list, roles, headcount, locations and timeline to the employer-service team. Employees needing an individual visit should use the relevant patient intake path and employer authorization. Urgent clinical care should not wait for a sales or program-design meeting.
In a DOT program, the MRO reviews applicable laboratory findings and asks for medical information when needed. Keep accurate contact details and prescription records available. Do not assume that telling the collector about a prescription completes verification or establishes fitness for safety-sensitive work.
Hair follicle testing can fit selected employer-policy programs when scoped in advance.
Employers should confirm collection type before employees are routed.
Regulated programs may require specific test types and should be handled separately.
Review covered roles, test type, timing, geography, forms, and reporting expectations before employees are routed.
Choose clinic, mobile, collection-site, lab, or account-managed workflows based on the service and workforce.
Give employees and managers clear instructions, then track visits, specimens, paperwork, and exceptions.
Route completion, pending items, and follow-up needs back to the agreed employer contact.
Program administration for employer drug and alcohol testing workflows.
Corporate Health services that fit inside TPA client workflows.
Physicals, labs, testing, vaccines, and injury care for companies.
Role-based screening packages for hiring and compliance programs.
Random pool, selection, collection, and reporting support.
Review workflow coordination connected to lab and employer reporting.
Mobile collection planning for worksites and distributed teams.
Urgent event routing for supervisors and safety teams.
Agency-style program coordination for city, state, transit, and public safety teams.
CBC, CMP, titers, Quantiferon, and employee lab workflows.
PPD, Quantiferon, and TB screening documentation for employers.
Work-status and fitness-for-duty coordination for employers.
Procurement-ready scope, reporting, references, and implementation planning.
Coordinate clinic, collection-site, lab, and mobile routes for multi-state teams.
Coordinate drug-testing and clinical-lab workflows through approved lab paths.
Define after-hours and urgent event routes before incidents happen.
Testing programs for agency, transit, corrections, and public safety teams.